MedPath

Effects of Melatonin on the incidence of Delirium

Phase 3
Conditions
Delirium.
Other delirium
Registration Number
IRCT20150928024236N5
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
140
Inclusion Criteria

Patients age 30 and over with less than 24 hours duration from ICU admission
Patients with Glasgow coma scale (GCS) > 8
Patients without mechanical ventilation
Patients with informed consent

Exclusion Criteria

History of delirium or mood disorder before ICU admission
Trauma and intracranial hemorrhage
Receive medications such as Benzodiazepines
History of epilepsy, seizure attack

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Delirium. Timepoint: Daily (from initial of study for 7 days). Method of measurement: Questionnaire of CAM-ICU.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath